Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage
Michelle Lipski, Stacy Pasciolla, Kevin Wojcik, Brian T. Jankowitz, Lauren Igneri
Topics & Concepts
MedicineRivaroxabanApixabanProthrombin complex concentrateIntensive care unitHemostasisAnesthesiaInternal medicineRetrospective cohort studyCohortSurgeryWarfarinAtrial fibrillationIntracerebral and Subarachnoid Hemorrhage ResearchAtrial Fibrillation Management and OutcomesNeurosurgical Procedures and Complications